Share-based Payment Arrangement, Expense of BioCorRx Inc. from 31 Dec 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BioCorRx Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2015 to 30 Sep 2025.
  • BioCorRx Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $16,060, a 45% decline year-over-year.
  • BioCorRx Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $203,282, a 64% increase year-over-year.
  • BioCorRx Inc. annual Share-based Payment Arrangement, Expense for 2024 was $229,599, a 259% increase from 2023.
  • BioCorRx Inc. annual Share-based Payment Arrangement, Expense for 2023 was $63,941, a 42% decline from 2022.
  • BioCorRx Inc. annual Share-based Payment Arrangement, Expense for 2022 was $111,079, a 1175% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BioCorRx Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $203,282 $16,060 -$13,201 -45% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $216,483 $30,715 +$235 +0.77% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $216,248 $35,099 -$13,351 -28% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2024 Q1
Q4 2024 $229,599 $121,408 +$105,699 +673% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $123,900 $29,261 +$13,056 +81% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $110,844 $30,480 +$14,527 +91% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $96,317 $48,450 +$32,376 +201% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2024 Q1
Q4 2023 $63,941 $15,709 -$3,667 -19% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $67,608 $16,205 -$7,121 -31% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $74,729 $15,953 +$458 +3% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $74,271 $16,074 -$36,808 -70% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $111,079 $19,376 +$19,376 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $91,703 $23,326 +$23,326 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $68,377 $15,495 +$11,809 +320% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $56,568 $52,882 +$47,853 +952% 01 Jan 2022 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $8,715 $0 -$10,963 -100% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $19,678 $0 -$7,827 -100% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $27,505 $3,686 -$5,517 -60% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $33,022 $5,029 -$43,738 -90% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $76,760 $10,963 -$18,073 -62% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $94,833 $7,827 -$3,861 -33% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $98,694 $9,203 -$693,911 -99% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
Q1 2020 $792,605 $48,767 -$902,048 -95% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 $1,694,653 $29,036 -$1,212,507 -98% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $2,907,160 $11,688 -$939,126 -99% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 $3,846,286 $703,114 +$624,579 +795% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2
Q1 2019 $3,221,707 $950,815 +$872,280 +1111% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q4 2018 $2,349,427 $1,241,543 +$1,163,007 +1481% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 $1,186,420 $950,814 +$866,961 +1034% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $319,459 $78,535 -$1 -0% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $319,460 $78,535 $0 0% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 $319,460 $78,536 $0 0% 01 Oct 2017 31 Dec 2017 10-K 16 Apr 2019 2018 FY
Q3 2017 $319,460 $83,853 +$5,318 +6.8% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $314,142 $78,536 +$52,358 +200% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $261,784 $78,535 +$78,535 01 Jan 2017 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 $183,249 $78,536 01 Oct 2016 31 Dec 2016 10-K 13 Apr 2017 2016 FY
Q3 2016 $78,535 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $26,178 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017 2017 Q2
Q1 2016 $0 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1

BioCorRx Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $229,599 +$165,658 +259% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $63,941 -$47,138 -42% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $111,079 +$102,364 +1175% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $8,715 -$68,045 -89% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $76,760 -$1,617,893 -95% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $1,694,653 -$654,774 -28% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $2,349,427 +$2,029,967 +635% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
2017 $319,460 +$136,211 +74% 01 Jan 2017 31 Dec 2017 10-K 16 Apr 2019 2018 FY
2016 $183,249 +$2,713 +1.5% 01 Jan 2016 31 Dec 2016 10-K 13 Apr 2017 2016 FY
2015 $180,536 01 Jan 2015 31 Dec 2015 10-K 13 Apr 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.